Pharmaceutical Executive Europe - August 2008 - (Page 12) 12 Strategy Fundamentals August 2008 Pharmaceutical Executive Europe Built on Sand Dr Brian D. Smith looks at the value of management science to real-world pharmaceutical executives. built on sand” out at “C athedralsthe transcript ofwas an expression that leapt a senior me from my research interview with executive recently. As I read it, I remembered how he had motioned towards a very thick business plan document. His point was that a strategic plan is, mostly, about how we anticipate and react to market changes and, if our understanding of those changes is weak or flawed, then the plan is too. It was a telling metaphor, equating the elaborate construction of analyses, forecasts and strategy recommendations to a medieval edifice that, however awe-inspiring, was only as strong as the foundations on which it was built. The interviewee, and I suspect most realistic executives, was aware of how weak those foundations sometimes are. Why is this so? Why does much of the work of market analysts and management teams result in so much data but so little understanding? The field of management cognition has, in the past 25 years, emerged from its home in psychology departments to become a thriving area of study in several leading business schools. And what that research tells us is useful to executives seeking to improve their decision making. The first practical lesson to learn from this work is how far realworld executives are from the theoretical, perfectly informed and perfectly rational ‘homo economicus.’ This gap was first illuminated as far back as 1947, with Herbert Simon’s concept of ‘bounded rationality’ — the idea that people were rational but only within the limits of what they know. Simon described how we use heuristics or rules of thumb to allow us to make complex decisions in a practical amount of time. He recognised that executives rarely make the best possible decision. Instead, they make “good enough” decisions, a process he called “satisficing.” In practice, satisficing in strategic decision making is usually necessary and accepting that fact makes executive teams adaptable and effective. The second practical lesson emerges when we look at how executive teams within a firm make sense of their market environment in order to create strategy. Here, the work of a group at Illinois, US, including Anne Huff and Charles Schwenk, is very interesting, as is the work of the UK’s Paul Sparrow and Gerard Hodgkinson. Their studies of how executives frame and categorise knowledge give real insight into the limitations of strategic decision making and how it might be improved by, for example, being aware of the inherent flaws in our cognitive processes. In terms of what we might do differently in light of this knowledge, some important recommendations emerge. Valuing diversity in perspective is one lesson, as is the danger of homogenising executive teams by recruitment, and pressure to confirm with company culture. Other lessons relate to how we value knowledge of different types. Many management cultures, for Why does much of the work of market analysts and management teams result in so much data but so little understanding? example, are strongly ‘positivist’ in that they value hard data above all else. However, effective teams seem to be able to synthesise hard and soft information without relegating one or the other. Diverse teams that weave together knowledge from many different sources are what is needed, this research tells us. Such insights from management research are easily dismissed as nothing new of course, but typical practice in the pharmaceutical industry suggests that not all firms have learnt these lessons. Benchmarking within the industry is still much more common than external-referencing and dampens diversity of thought. Consensus management and strong cultural pressures often ensure that dissenting thoughts are smothered. Even when we seek outside help from consultants, we demand ‘industry knowledge’ and so simply employ more industry insiders. And above all, the scientific ethos of our industry still places, instinctively, higher value on information expressed in numbers than it does on knowledge written in text. As a result, many of the cathedral-like plans we labour to construct, however weighty, are built on sand. About the Author Dr Brian D. Smith is a researcher, author and consultant in the field of competitive strategy and runs PragMedic, a specialist strategy consultancy. He welcomes comments and questions to brian.smith@pragmedic.com. http://www.pragmedic.com
Table of Contents Feed for the Digital Edition of Pharmaceutical Executive Europe - August 2008 Pharmaceutical Executive Europe - August 2008 Contents From the Editor News and Analysis Calendar The Calm Before the Storm Steering Pharma in Russia Built on Sand Renaissance Man IT Meets IMI Send for the Software Specialists Know Your eMarket Last Words Pharmaceutical Executive Europe - August 2008 Pharmaceutical Executive Europe - August 2008 - Pharmaceutical Executive Europe - August 2008 (Page Cover1) Pharmaceutical Executive Europe - August 2008 - Pharmaceutical Executive Europe - August 2008 (Page Cover2) Pharmaceutical Executive Europe - August 2008 - Contents (Page 3) Pharmaceutical Executive Europe - August 2008 - Contents (Page 4) Pharmaceutical Executive Europe - August 2008 - From the Editor (Page 5) Pharmaceutical Executive Europe - August 2008 - News and Analysis (Page 6) Pharmaceutical Executive Europe - August 2008 - News and Analysis (Page 7) Pharmaceutical Executive Europe - August 2008 - Calendar (Page 8) Pharmaceutical Executive Europe - August 2008 - Calendar (Page 9) Pharmaceutical Executive Europe - August 2008 - The Calm Before the Storm (Page 10) Pharmaceutical Executive Europe - August 2008 - Steering Pharma in Russia (Page 11) Pharmaceutical Executive Europe - August 2008 - Built on Sand (Page 12) Pharmaceutical Executive Europe - August 2008 - Renaissance Man (Page 13) Pharmaceutical Executive Europe - August 2008 - Renaissance Man (Page 14) Pharmaceutical Executive Europe - August 2008 - IT Meets IMI (Page 15) Pharmaceutical Executive Europe - August 2008 - IT Meets IMI (Page 16) Pharmaceutical Executive Europe - August 2008 - IT Meets IMI (Page 17) Pharmaceutical Executive Europe - August 2008 - Send for the Software Specialists (Page 18) Pharmaceutical Executive Europe - August 2008 - Send for the Software Specialists (Page 19) Pharmaceutical Executive Europe - August 2008 - Know Your eMarket (Page 20) Pharmaceutical Executive Europe - August 2008 - Know Your eMarket (Page 21) Pharmaceutical Executive Europe - August 2008 - Last Words (Page 22)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.